Clonazepam study works with European practice in status epilepticus By Eleanor McDermid.

Altogether, 72 patients in today’s study received clonazepam as a first-collection agent, 82 received lorazepam and 23 were given midazolam. The experts found a big difference in the proportion of patients who had been refractory to each medication, with 50.85 percent and 42.86 percent requiring a different anti-epileptic drug after usage of clonazepam and midazolam, respectively, compared with 89.47 percent after use of lorazepam.Only 9.4 % of sufferers in the sigmoidoscopy group and 10.8 % of patients in the colonoscopy group considered sedation essential for the procedure. The patient’s sex and the endoscopist who performed the procedure, but not the type of procedure, were associated with severity of discomfort and need for sedation. Women were much more likely to request or demonstrate a desire to have sedation. Researchers acknowledged some scholarly study limitations, specifically that the decision between colonoscopy or sigmoidoscopy was not random, but rather was subject to the patient’s preference as the examinations had been self-paid.

Related Posts

Other Posts From Category "dermatology":